Table 1.
Patient and mother baseline characteristics
| Variable | Total episodes (n = 480) |
|---|---|
| Age of the mother (years) | 30 (18–43) |
| Hypertension Pregnancy Disorder (PIH/PE) | 107 (22.3%) |
| Gestational diabetes | 33 (6.9%) |
| pPROMa | 85 (17.7%) |
| Maternal Fever | 22 (4.6%) |
| Antenatal corticosteroid therapyb | |
| None | 64 (13.3%) |
| 1 dose of betamethasone | 113 (23.5%) |
| 2 doses of betamethasone | 295 (61.5%) |
| Singleton | 386 (80.4%) |
| Sex (male) | 249 (51.9%) |
| Gestational Age (weeks) | 26 + 3 (24 + 0 – 31 + 6) |
| Post menstrual age (weeks) | 29 + 1 (24 + 4 – 51 + 3) |
| Birthweight (grams) | 850 (445–2100) |
| Age at Evaluation (days) | 13 (4–165) |
| IL-6 level at onset (pg/mL) | 45 (2–1396700) |
| PCT level at onset (ng/mL) | 0.67 (0.02 – 100) |
| CRP level at onset (mg/L) | 3.45 (0.3 – 309.0) |
| Mortality | 24 (5%) |
| Type of infection | |
| No infection | 337 (70.2%) |
| Culture negative | 56 (11.7%) |
| Culture proven sepsis | 87 (18.1%) |
| Gram positive (% of total proven sepsis) | 63 (72%) |
| CoNSc | 42 (48%) |
| S. aureus | 14 (16%) |
| Others | 7 (8%) |
| Gram negative (% of total proven sepsis) | 24 (28%) |
| E.Coli | 17 (19%) |
| Klebsiella | 4 (5%) |
| Others | 3 (4%) |
| nSOFA score | |
| nSOFA score at t = 12 h | 0 (0–11) |
| Number of suspected episode | |
| 1 suspected episode | 84 |
| 2 suspected episode | 46 |
| > 2 suspected episodes | 78 |
aProlonged premature rupture of membranes
bNumber of doses of antenatal betamethasone therapy
cCoagulase negative staphylococci
Values are medians (min–max range) or percentages